Medical Innovation Centers of America, INC.

What Medical Innovation Centers of America, INC. does

Medical Innovation Centers of America, Inc. (MICA) is a Texas-incorporated C-Corporation, founded in 2023 and operating primarily from Oklahoma City with a secondary office in Bogotá, Colombia. The company positions itself as a healthcare technology and services provider, with a stated core focus on revenue cycle management, AI-driven healthcare automation, managed care technology, and advanced therapeutics for chronic conditions. MICA builds and markets proprietary platforms including an OCR Automated Payment Posting engine that converts PDF remittances into CSV files for accounting/EMR upload, an Automated Inventory Management system performing 3-way PO/GRN/Invoice matching, an AI-Assisted Patient Referrals platform integrated with EMR and electronic fax, and an AI Nurse Partner autonomous virtual nursing assistant that handles protocol-based tasks such as home medication review, purposeful rounding, and post-discharge support.

Underlying technology combines machine learning, robotic process automation (RPA), natural language processing (NLP), and computer-vision OCR, supplemented by a strategic partnership with Intelligent HealthTech AI in California. Beyond its healthcare software portfolio, MICA operates as the exclusive national and international distributor of the Healgen Rapid Check COVID-19/Flu A&B Antigen Test, and offers end-to-end Medical Solar Solutions, Global Uranium Brokerage, and Strategic Political & International Services. Stated revenue streams include managed service contracts, technology licensing, SaaS subscriptions, and equity stakes in funded healthcare innovation organizations. The go-to-market is enterprise sales-led, with healthcare organizations as the primary customer segment, supported by demo requests, direct phone outreach, and social media presence on Instagram, X, and LinkedIn.

The company is small (1-10 employees), founder-led by CEO Kevin McDugle and COO Christian Calhoun, and has raised approximately $1.125 million across two 2024 funding events, including a $500,000 Series B Preferred Stock offering filed under SEC Regulation D. Bison Financial Partners serves as third-party financial management, and the company maintains dedicated investor relations channels.

Name

Medical Innovation Centers of America, INC.

Legal name

Medical Innovation Centers of America, Inc.

Website

https://medicalinnovationcenters.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Headquarters

HQ city

Oklahoma City

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Managed Service Contracts: Primary revenue stream through ongoing managed service agreements with healthcare organizations for technology and operational services
2. Technology Licensing: Revenue generated from licensing proprietary AI and automation technologies to healthcare organizations
3. SaaS Subscriptions: Software-as-a-service revenue from cloud-based platforms including revenue cycle management and AI nurse partner solutions
4. Equity Stakes: MICA holds equity stakes in various funded healthcare innovation organizations as an investment and strategic positioning mechanism

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

MICA is a healthcare technology and services company that provides AI-driven automation, revenue cycle management, managed care technology, and advanced therapeutic services to healthcare organizations. The company develops and deploys proprietary platforms including an AI Nurse Partner, OCR-based payment posting, automated inventory management, and AI-assisted patient referral systems, while also serving as an exclusive distributor for the Healgen Rapid Check COVID-19/Flu A&B Antigen Test and offering medical solar energy and uranium brokerage services.

Product overview

MICA operates as a diversified healthcare technology and services company offering a multi-product portfolio centered on AI-driven healthcare innovation. The core offerings include Revenue Cycle Management Services (with OCR Automated Payment Posting), Artificial Intelligence Automation Services (featuring the AI Nurse Partner module), Managed Care Technology Services, and Advanced Therapeutic Services. MICA also serves as exclusive distributor of the Healgen Rapid Check COVID-19/Flu A&B Antigen Test and provides Medical Solar Solutions for healthcare facilities. Additional services include Global Uranium Brokerage and Strategic Political Services. The AI platform powers process automation through OCR, inventory management, and patient referral features, while the AI Nurse Partner provides autonomous agent capabilities for routine clinical tasks. Revenue streams derive from managed service contracts, technology licensing, SaaS models, and equity stakes in healthcare innovation organizations.

Differentiator

Problem solved

Functional benefit

Products and services

• Revenue Cycle Management Services Automation services that streamline financial workflows for healthcare organizations using cutting-edge technology and industry best practices, including OCR-based payment posting.
• AI Automation Services AI-powered automation services for healthcare organizations leveraging advanced algorithms, machine learning, NLP, and RPA to optimize healthcare workflows, enhance patient care, and drive operational efficiency.
• Managed Care Technology Services Technology solutions for healthcare organizations to navigate complex managed care landscapes, ensuring enhanced patient outcomes and cost-effective care delivery.
• Advanced Therapeutic Services Personalized treatment plans and innovative approaches for cardiovascular disease, diabetes, and other chronic conditions, integrating the latest research findings.
• Healgen Rapid Check COVID-19/Flu A&B Antigen Test Rapid antigen test that differentiates COVID-19, Influenza A, and Influenza B in a single test with 15-minute results. Distributed exclusively by MICA nationally and internationally. Clinical accuracy: SARS-CoV-2 92.0% PPA/99.0% NPA, Flu A 92.5% PPA/99.9% NPA, Flu B 90.5% PPA/99.9% NPA.
• Medical Solar Solutions End-to-end solar energy systems for medical, hospital, and healthcare facilities including site survey, design, EPC, electrical/mechanical integration, O&M, incentive optimization, and financing with PPAs, leases, and capex structures.
• AI Nurse Partner AI-powered virtual nursing assistant that automates routine protocol-based responsibilities including home medication review, purposeful rounding, patient education, post-discharge support, pre-op checks, and pain reassessments. Enables concurrent patient engagement.
• Strategic Political and International Services Strategic introductions and relationship facilitation across federal and international arenas in medical, energy, minerals, and international policy sectors through verified political relationships.
• Global Uranium Brokerage

Quantifiable outcome

• AI Nurse Partner enables concurrent patient engagement while reducing nurses' workload
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability10 records

Feature6 records

Partnerships

Four partnerships are on record, tiered core and major.

• Intelligent HealthTech AIcoreTechnology or IntegrationMICA has strategically partnered with Intelligent HealthTech AI, a leading company in California specializing in cutting-edge artificial intelligence solutions for the healthcare sector. This partnership enhances MICA's AI automation capabilities.
• Oklahoma State UniversitycoreStrategic or Co-development PartnerMICA has joined forces with Oklahoma State University in an unprecedented partnership facilitating groundbreaking advancements in biomedical engineering and technology using MICA's AI platform.
• Healgen ScientificcoreChannel Partner/ Reseller/ DistributorMICA serves as the exclusive national and international distributor of the Healgen Rapid Check COVID-19/Flu A&B Antigen Test, providing fast, reliable diagnostic results for three major respiratory illnesses.
• Strategic Solar FirmsmajorChannel Partner/ Reseller/ DistributorMICA partners with leading solar firms to bring clean, efficient, and cost-effective solar energy systems to medical, hospital, and health care facilities worldwide.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Cedar: Cedar provides an AI-driven patient billing and engagement platform for healthcare providers, focused on improving the financial experience through personalization and automation. It is a direct comparable to MICA's patient-side RCM and engagement modules.
• Infinx: Infinx delivers AI-driven patient access and revenue cycle solutions for healthcare providers, including prior authorization and AR management. Its automation-led RCM focus closely mirrors MICA's OCR and automation positioning.
• AKASA: AKASA builds AI-native automation specifically for healthcare revenue cycle operations, targeting the same back-office workflows (claims status, prior auth, denials) as MICA's RCM platform with a similarly AI-first architecture.
• Notable: Notable offers an AI platform for healthcare automation spanning patient intake, scheduling, billing, and clinical workflow — directly overlapping with MICA's patient referrals, EMR integration, and AI automation modules.

Emerging players

• Olive AI: Olive AI was a healthcare AI automation company targeting revenue cycle and administrative workflows using RPA and machine learning — effectively the same thesis as MICA's AI automation platform. (Note: Olive wound down core operations in 2023, which is itself instructive for the category's execution difficulty.)

Broad incumbents

• Tempus AI: Tempus AI is a health technology company applying AI to clinical and operational data, with adjacent capabilities in clinical decision support and predictive analytics that overlap with the AI capabilities MICA markets.
• Waystar: Waystar is a leading cloud-based revenue cycle management platform serving hospitals and health systems with claims management, patient billing, and analytics. It is broadly comparable to MICA's core RCM automation offering, though at vastly greater scale and product depth.
• R1 RCM: R1 RCM is a major enterprise revenue cycle management company serving large hospital systems, with end-to-end patient access, billing, and collections services. It is the largest scaled competitor in MICA's primary RCM niche.
• Health Catalyst: Health Catalyst is a healthcare data and analytics platform serving hospital systems, with adjacent predictive analytics and operational improvement capabilities similar to those claimed by MICA's predictive analytics and clinical decision support modules.

Others

• Definitive Healthcare: Definitive Healthcare provides commercial intelligence and analytics for the healthcare industry, enabling sales and marketing organizations targeting providers. It is thematically adjacent as a healthcare data/analytics platform rather than a direct RCM competitor.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/medinnovcenters
• LinkedInlinkedin.com/company/medinnovcenters
• Instagraminstagram.com/medinnovcenters

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medical Innovation Centers of America, INC.